Ambev S.A. (ABEV) Forms $6.58 Double Top; Houlihan Lokey (HLI) Shorts Decreased By 6.03%

Ambev S.A. (ABEV) formed double top with $6.78 target or 3.00% above today’s $6.58 share price. Ambev S.A. (ABEV) has $105.42B valuation. The stock decreased 2.52% or $0.17 during the last trading session, reaching $6.58. About 22.25M shares traded or 33.38% up from the average. Ambev S.A. (NYSE:ABEV) has risen 10.52% since February 6, 2017 and is uptrending. It has underperformed by 6.18% the S&P500.

Houlihan Lokey Incorporated (NYSE:HLI) had a decrease of 6.03% in short interest. HLI’s SI was 751,000 shares in February as released by FINRA. Its down 6.03% from 799,200 shares previously. With 160,800 avg volume, 5 days are for Houlihan Lokey Incorporated (NYSE:HLI)’s short sellers to cover HLI’s short positions. The stock decreased 4.77% or $2.26 during the last trading session, reaching $45.08. About 275,410 shares traded or 34.89% up from the average. Houlihan Lokey, Inc. (NYSE:HLI) has risen 49.19% since February 6, 2017 and is uptrending. It has outperformed by 32.49% the S&P500.

Houlihan Lokey, Inc., an investment banking company, provides mergers and acquisitions , financings, financial restructurings, and financial advisory services in the United States, Canada, Europe, Asia, Australia, the Middle East, Latin America, and Africa. The company has market cap of $2.97 billion. The Company’s Corporate Finance segment offers general financial advisory services on M&A and capital markets offerings; advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions; and advises financial sponsors on various transactions. It has a 17.75 P/E ratio. This segment also provides financing solutions and capital-raising advisory services for publicly-held and multinational firms, financial sponsors, and privately-held companies.

Among 8 analysts covering Houlihan Lokey (NYSE:HLI), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. Houlihan Lokey had 17 analyst reports since September 8, 2015 according to SRatingsIntel. As per Thursday, August 18, the company rating was downgraded by Sandler O’Neill. The firm has “Outperform” rating by Keefe Bruyette & Woods given on Tuesday, September 8. Bank of America maintained the shares of HLI in report on Wednesday, October 25 with “Neutral” rating. Sandler O’Neill initiated it with “Buy” rating and $25.0 target in Tuesday, September 8 report. Bank of America downgraded the stock to “Neutral” rating in Thursday, May 11 report. The firm earned “Buy” rating on Wednesday, October 25 by UBS. The firm earned “Mkt Outperform” rating on Tuesday, September 8 by JMP Securities. UBS maintained it with “Buy” rating and $42 target in Wednesday, July 26 report. Keefe Bruyette & Woods maintained it with “Buy” rating and $40.0 target in Sunday, August 27 report. J.P. Morgan initiated Houlihan Lokey, Inc. (NYSE:HLI) on Tuesday, September 12 with “Buy” rating.

Analysts await Ambev S.A. (NYSE:ABEV) to report earnings on March, 1. They expect $0.10 EPS, up 25.00% or $0.02 from last year’s $0.08 per share. ABEV’s profit will be $1.60B for 16.45 P/E if the $0.10 EPS becomes a reality. After $0.06 actual EPS reported by Ambev S.A. for the previous quarter, Wall Street now forecasts 66.67% EPS growth.